Otsuka Holdings Takes Aim at 915 Billion Yen Pharma Sales in FY2018 after Abilify Patent Loss

Otsuka Holdings President Tatsuo Higuchi Otsuka Holdings will work to achieve pharmaceutical sales and operating profit of 915 billion yen and 190 billion yen by FY2018, it stated in its latest midterm business plan released on August 26. According to...read more